4.7 Article

Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue

期刊

出版社

MDPI
DOI: 10.3390/ijms19061585

关键词

Src; Ras; Raf; PTEN; PI3K; cooperative tumourigenesis; Drosophila

资金

  1. NIH [1R21CA098997-01]
  2. Wellcome Trust
  3. National Health and Medical Research Council (NHMRC) [299842, 454700]
  4. Peter MacCallum Cancer Centre
  5. La Trobe Institute of Molecular Science
  6. La Trobe University
  7. NHMRC [350396, 1142469]
  8. University of Melbourne
  9. National Health and Medical Research Council of Australia [1142469] Funding Source: NHMRC

向作者/读者索取更多资源

The Ras oncogene (Rat Sarcoma oncogene, a small GTPase) is a key driver of human cancer, however alone it is insufficient to produce malignancy, due to the induction of cell cycle arrest or senescence. In a Drosophila melanogaster genetic screen for genes that cooperate with oncogenic Ras (bearing the Ras(V12) mutation, or Ras(ACT)), we identified the Drosophila Src (Sarcoma virus oncogene) family non-receptor tyrosine protein kinase genes, Src42A and Src64B, as promoting increased hyperplasia in a whole epithelial tissue context in the Drosophila eye. Moreover, overexpression of Src cooperated with Ras(ACT) in epithelial cell clones to drive neoplastic tumourigenesis. We found that Src overexpression alone activated the Jun N-terminal Kinase (JNK) signalling pathway to promote actin cytoskeletal and cell polarity defects and drive apoptosis, whereas, in cooperation with Ras(ACT), JNK led to a loss of differentiation and an invasive phenotype. Src + Ras(ACT) cooperative tumourigenesis was dependent on JNK as well as Phosphoinositide 3-Kinase (PI3K) signalling, suggesting that targeting these pathways might provide novel therapeutic opportunities in cancers dependent on Src and Ras signalling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据